Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-20-020855)

Filing Details

Accession Number:: 0001437749-20-020855
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-10-07 17:06:03
Reporting Period:: 2020-10-06

Accepted Time:: 2020-10-07 17:06:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1384101	Veracyte Inc.	VCYT	Services-Medical Laboratories (8071)	205455398

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1769333	C Giulia Kennedy	6000 Shoreline Court Suite 300 South San Francisco CA 94080	Chief Scientific & Med Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-10-06	2,500	$20.21	81,899	No	4	M	Direct
Common Stock	Disposition	2020-10-06	2,500	$35.21	79,399	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-10-06	2,500	$0.00	2,500	$20.21

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
37,500		2029-02-27	No	4	M	Direct

Footnotes

The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020.
The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuousservice thereafter.